vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
Orange County Bancorp, Inc. is the larger business by last-quarter revenue ($33.0M vs $19.2M, roughly 1.7× Apyx Medical Corp). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -6.8%, a 44.4% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs 20.6%). Orange County Bancorp, Inc. produced more free cash flow last quarter ($41.3M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs 14.3%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
APYX vs OBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $33.0M |
| Net Profit | $-1.3M | $12.4M |
| Gross Margin | 62.6% | — |
| Operating Margin | 0.1% | 41.4% |
| Net Margin | -6.8% | 37.6% |
| Revenue YoY | 34.7% | 20.6% |
| Net Profit YoY | 71.9% | 73.5% |
| EPS (diluted) | — | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $33.0M | ||
| Q3 25 | $12.9M | $33.7M | ||
| Q2 25 | $11.4M | $32.5M | ||
| Q1 25 | $9.4M | $28.0M | ||
| Q4 24 | $14.2M | $27.4M | ||
| Q3 24 | $11.5M | $27.1M | ||
| Q2 24 | $12.1M | $27.9M | ||
| Q1 24 | $10.2M | $25.3M |
| Q4 25 | $-1.3M | $12.4M | ||
| Q3 25 | $-2.0M | $10.0M | ||
| Q2 25 | $-3.8M | $10.5M | ||
| Q1 25 | $-4.2M | $8.7M | ||
| Q4 24 | $-4.6M | $7.2M | ||
| Q3 24 | $-4.7M | $3.2M | ||
| Q2 24 | $-6.6M | $8.2M | ||
| Q1 24 | $-7.6M | $9.3M |
| Q4 25 | 62.6% | — | ||
| Q3 25 | 64.4% | — | ||
| Q2 25 | 62.3% | — | ||
| Q1 25 | 60.1% | — | ||
| Q4 24 | 63.0% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | — | ||
| Q1 24 | 58.1% | — |
| Q4 25 | 0.1% | 41.4% | ||
| Q3 25 | -6.5% | 38.6% | ||
| Q2 25 | -22.6% | 41.9% | ||
| Q1 25 | -32.4% | 40.3% | ||
| Q4 24 | -21.4% | 32.8% | ||
| Q3 24 | -31.6% | 14.8% | ||
| Q2 24 | -45.7% | 36.6% | ||
| Q1 24 | -64.6% | 45.9% |
| Q4 25 | -6.8% | 37.6% | ||
| Q3 25 | -15.4% | 29.7% | ||
| Q2 25 | -33.2% | 32.2% | ||
| Q1 25 | -44.0% | 31.1% | ||
| Q4 24 | -32.5% | 26.2% | ||
| Q3 24 | -40.9% | 11.8% | ||
| Q2 24 | -54.0% | 29.4% | ||
| Q1 24 | -74.0% | 36.7% |
| Q4 25 | — | $0.94 | ||
| Q3 25 | — | $0.75 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | $-0.19 | $0.73 | ||
| Q1 24 | $-0.22 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | — |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $284.4M |
| Total Assets | $66.8M | $2.7B |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | — | ||
| Q3 25 | $25.1M | — | ||
| Q2 25 | $29.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $31.7M | — | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $32.7M | — | ||
| Q1 24 | $37.3M | — |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $284.4M | ||
| Q3 25 | $5.8M | $270.1M | ||
| Q2 25 | $7.3M | $252.6M | ||
| Q1 25 | $10.5M | $201.3M | ||
| Q4 24 | $14.2M | $185.5M | ||
| Q3 24 | $11.0M | $193.1M | ||
| Q2 24 | $14.7M | $177.5M | ||
| Q1 24 | $20.3M | $168.7M |
| Q4 25 | $66.8M | $2.7B | ||
| Q3 25 | $57.4M | $2.6B | ||
| Q2 25 | $58.2M | $2.6B | ||
| Q1 25 | $60.2M | $2.6B | ||
| Q4 24 | $64.8M | $2.5B | ||
| Q3 24 | $60.7M | $2.5B | ||
| Q2 24 | $65.4M | $2.5B | ||
| Q1 24 | $70.7M | $2.5B |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $43.8M |
| Free Cash FlowOCF − Capex | $-2.8M | $41.3M |
| FCF MarginFCF / Revenue | -14.6% | 125.1% |
| Capex IntensityCapex / Revenue | 1.4% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $43.8M | ||
| Q3 25 | $-3.5M | $30.2M | ||
| Q2 25 | $-1.2M | $-5.0M | ||
| Q1 25 | $-702.0K | $4.8M | ||
| Q4 24 | $-2.9M | $34.6M | ||
| Q3 24 | $-4.4M | $10.2M | ||
| Q2 24 | $-4.3M | $9.3M | ||
| Q1 24 | $-6.3M | $2.3M |
| Q4 25 | $-2.8M | $41.3M | ||
| Q3 25 | $-4.1M | $29.6M | ||
| Q2 25 | $-1.5M | $-5.7M | ||
| Q1 25 | $-757.0K | $4.3M | ||
| Q4 24 | $-3.2M | $32.9M | ||
| Q3 24 | $-4.6M | $10.0M | ||
| Q2 24 | $-4.6M | $9.2M | ||
| Q1 24 | $-6.4M | $2.0M |
| Q4 25 | -14.6% | 125.1% | ||
| Q3 25 | -31.5% | 87.8% | ||
| Q2 25 | -13.2% | -17.5% | ||
| Q1 25 | -8.0% | 15.5% | ||
| Q4 24 | -22.4% | 120.0% | ||
| Q3 24 | -40.0% | 36.7% | ||
| Q2 24 | -38.0% | 32.8% | ||
| Q1 24 | -62.2% | 7.9% |
| Q4 25 | 1.4% | 7.6% | ||
| Q3 25 | 4.0% | 1.8% | ||
| Q2 25 | 2.3% | 2.3% | ||
| Q1 25 | 0.6% | 1.8% | ||
| Q4 24 | 1.7% | 6.3% | ||
| Q3 24 | 1.3% | 1.1% | ||
| Q2 24 | 2.4% | 0.4% | ||
| Q1 24 | 0.3% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 4.83× | ||
| Q3 24 | — | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
